Future HIV Vaccine Acceptability Among Young Adults in South Africa

被引:29
|
作者
Sayles, Jennifer N. [1 ]
Macphail, Catherine L. [2 ]
Newman, Peter A. [3 ]
Cunningham, William E.
机构
[1] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA 90024 USA
[2] Univ Witwatersrand, Johannesburg, South Africa
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
关键词
HIV vaccines; South Africa; youth; barriers; qualitative research; RISK; BARRIERS; TRIALS; WILLINGNESS; PARTICIPATE; KNOWLEDGE; WOMEN; AIDS; DETERMINANTS; COMMUNITIES;
D O I
10.1177/1090198109335654
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Developing and disseminating a preventive HIV vaccine is a primary scientific and public health objective. However, little is known about HIV vaccine acceptability in the high-prevalence setting of South Africa where young adults are likely to be targeted in early dissemination efforts. This study reports on six focus groups (n = 42) conducted in 2007 with South Africans aged 18 to 24 years. A deductive framework approach is used to identify key motivators and barriers to future HIV vaccine uptake. Participants identify HIV testing, HIV stigma, mistrust of the health care system, and concerns about sexual disinhibition as barriers to vaccine uptake. For women, family members and friends are strong motivators for vaccine uptake, whereas men are more likely to see vaccines as an opportunity to stop using HIV prevention strategies such as condoms and partner reduction. Implications of these findings for developing HIV vaccine dissemination strategies and policy in South Africa are discussed.
引用
收藏
页码:193 / 210
页数:18
相关论文
共 50 条
  • [1] HIV vaccine acceptability among South African youth
    Sayles, J. N.
    Macphail, C.
    Newman, P.
    Cunningham, W. E.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 315 - 315
  • [2] AFREVACC 001: feasibility and acceptability of an HIV vaccine trial among men in Johannesburg, South Africa
    Delany-Moretlwe, S.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 4 - 4
  • [3] HIV vaccine acceptability among women at risk: Perceived barriers and facilitators to future HIV vaccine uptake
    Rudy, ET
    Newman, PA
    Duan, NH
    Kelly, EM
    Roberts, KJ
    Seiden, DS
    [J]. AIDS EDUCATION AND PREVENTION, 2005, 17 (03) : 253 - 267
  • [4] Prevalence and Acceptability of Male Circumcision among Young Men in South Africa
    Peltzer, Karl
    Mlambo, Motlatso
    [J]. STUDIES ON ETHNO-MEDICINE, 2012, 6 (03) : 179 - 186
  • [5] Social and structural factors associated with vulnerability to HIV infection among young adults in South Africa
    Naidoo, Pamela
    Chirinda, Witness
    Mchunu, Gugu
    Swartz, Sharlene
    Anderson, Jaynia
    [J]. PSYCHOLOGY HEALTH & MEDICINE, 2015, 20 (03) : 369 - 379
  • [6] Disclosure and Experiences of HIV-Related Stigma among Adolescents and Young Adults Living with HIV in South Africa
    Nice, Johanna
    Thurman, Tonya R.
    Luckett, Brian
    Zani, Babalwa
    [J]. AIDS AND BEHAVIOR, 2024,
  • [7] HIV infection and AIDS among young women in South Africa
    Muula, Adamson S.
    [J]. CROATIAN MEDICAL JOURNAL, 2008, 49 (03) : 423 - 435
  • [8] Human papillomavirus and cervical cancer risk perception and vaccine acceptability among adolescent girls and young women in Durban, South Africa
    Russell, V. L.
    Ogilvie, G.
    Beksinska, M.
    Nyirenda, M.
    Mitchell-Foster, S.
    Lavoie, J.
    Harder, H.
    Wood, B.
    Smith, P.
    Dietrich, J. J.
    Smit, J.
    Brockman, M. A.
    Grag, G.
    Kaida, A.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (09): : 887 - 893
  • [9] Determinants of COVID-19 vaccine acceptability among older adults living with HIV
    Davtyan, Mariam
    Frederick, Toinette
    Taylor, Jeff
    Christensen, Christopher
    Brown, Brandon J.
    Nguyen, Annie L.
    [J]. MEDICINE, 2022, 101 (31)
  • [10] Attracting, Equipping and Retaining Young Investigators in HIV Vaccine Research in South Africa
    Flood, D.
    Wallace, M.
    Racow, K.
    Kublin, J.
    Bekker, L.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A69 - A70